Wenger Vieli acted as Swiss legal advisor to NLS Pharmaceutics on the issuance. NLS Pharmaceutics has completed the registered direct offering and concurrent private placement transaction with...
NLS Pharmaceutics’ Common Shares Private Placement
NLS Pharmaceutics’ $4 Million Private Placement and Conversion of Existing Short-Term Notes
Wenger Vieli advised NLS Pharmaceutics on the deal. NLS Pharmaceutics Ltd., a Swiss clinical-stage biopharmaceutical company focused on the discovery and development of innovative therapies for...
NLS Pharmaceutics’ US$4.4 Million Registered Direct Offering
Wenger Vieli advised NLS Pharmaceutics on the deal. NLS Pharmaceutics Ltd, a Swiss clinical-stage biopharmaceutical company focused on the discovery and development of innovative therapies for patients...
NLS Pharmaceutics’ US$4.4 Million Registered Direct Offering
Wenger Vieli advised NLS Pharmaceutics on the deal. NLS Pharmaceutics Ltd, a Swiss clinical-stage biopharmaceutical company focused on the discovery and development of innovative therapies for patients...